Shen, Yang, Xianwen Chen, Hao Zhang, and Hao Hu. “Long-Term Cost-Effectiveness Analysis of onceweekly Semaglutide Versus Dulaglutide for the Treatment of Type 2 Diabetes After the Renewal of the National Drug Reimbursement List in China”. Health Decision 2, no. S1 (July 12, 2024). Accessed May 2, 2025. https://www.hksmp.com/journals/hd/article/view/649.